Showing results (61-70 of 206) with videos related to

Sort By:
Pageof 21
Cardiovascular Research|July 6, 2006
Thrombospondin-1 antagonizes nitric oxide-stimulated vascular smooth muscle cell responsesJeff S Isenberg, David A Wink, David D Roberts
Arteriosclerosis, Thrombosis, and Vascular Biology|January 12, 2008
CD47: a new target in cardiovascular therapyJeff S Isenberg, David D Roberts, William A Frazier
Antibody Therapeutics|November 27, 2020
Preclinical and Clinical Development of Therapeutic Antibodies Targeting Functions of CD47 in the Tumor MicroenvironmentSukhbir Kaur, Kyle V Cicalese, Rajdeep Bannerjee, et al.
Methods in Cell Biology|January 10, 2018
Thrombospondins: Purification of human platelet thrombospondin-1John M Sipes, Joanne E Murphy-Ullrich, David D Roberts
Journal of Genetic Syndromes & Gene Therapy|June 12, 2012
Therapeutic Targeting of CD47 to Modulate Tissue Responses to Ischemia and RadiationDavid R Soto-Pantoja, Jeff S Isenberg, David D Roberts
The Journal of Biological Chemistry|January 10, 2014
Protein-tyrosine phosphatase 4A3 (PTP4A3) promotes vascular endothelial growth factor signaling and enables endothelial cell motilityMark W Zimmerman, Kelley E McQueeney, Jeffrey S Isenberg, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|March 19, 2013
Thrombospondin-1 is a CD47-dependent endogenous inhibitor of hydrogen sulfide signaling in T cell activationThomas W Miller, Sukhbir Kaur, Kelly Ivins-O'Keefe, et al.
Methods in Enzymology|March 10, 2015
CD47-dependent regulation of H₂S biosynthesis and signaling in T cellsSukhbir Kaur, Anthony L Schwartz, Thomas W Miller, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 1, 2015
Imaging Candida Infections in the HostDhammika H Navarathna, David D Roberts, Jeeva Munasinghe, et al.
Pageof 21